Waters Corporation
$481.35
+4.47 · +0.94% today
Market open · updated 12:44:26 PM ET
- High
- $481.35 Oct 29, 2026
- Low
- $301.88 May 4, 2026
Against the S&P 500 Price change through Oct 28, 2026
WAT+25.55%
S&P 500+13.26%
WAT+37.85%
S&P 500+12.41%
WAT+94.84%
S&P 500+88.06%
WAT+31.98%
S&P 500+68.51%
Key numbers
- Previous close
- $476.88
- Open
- $478.46
- Day's range
- $472.60 – $481.80
- 52-week range
- $282.77 – $482.28
- Volume
- 380,800
- Average volume
- 826,799
- Market value
- $47.3 billion
- Price to earnings
- 118.6last 12 months
- Earnings per share
- $1.69last 12 months
- Beta
- 1.15moves about as much as the market
- Dividend
- None
- 50-day average
- $427.74
- 200-day average
- $368.74
Tuesday, Nov 3, 2026, before the open.
Analyst price targets and the full financials are in the terminal.
Who Waters competes with From our value chain
Waters in the news
No desk stories on WAT yet. When we write about it, the story leads this list.
- HeadlineWaters Gears Up to Report Q3 Results: How to Play the Stock?Zacks Investment Research · October 28, 2026 at 2:56 PM ET
- HeadlineWaters Launches AI-Powered Peak Integration Expanding its Suite of Premium AI Subscription Capabilities for Empower SoftwarePRNewsWire · October 28, 2026 at 8:00 AM ET
- HeadlineWaters & Labcorp Expand Access to FDA-Approved HPV Screening TestsZacks Investment Research · October 27, 2026 at 1:36 PM ET
- HeadlineWaters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026PRNewsWire · October 23, 2026 at 8:00 AM ET
- HeadlineWaters Launches AI Link to Advance AI-Enabled LC-MS WorkflowsZacks Investment Research · October 20, 2026 at 11:20 AM ET
- HeadlineWaters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening OptionPRNewsWire · October 20, 2026 at 8:00 AM ET
- HeadlineTwo stocks poised to benefit from rotation out of AIInvezz · October 19, 2026 at 2:22 PM ET
- CongressKevin Hern sold $1,001 - $15,000 of WATHouse filing · disclosed Sep 2, 2026
Earnings
Next report: Tuesday, Nov 3, 2026, before the open.
Congress trades in WAT
5 purchases and 3 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Kevin HernHouse · R-Oklahoma | Sale | $1,001 - $15,000 | Aug 13, 2026 | Sep 2, 2026 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Apr 13, 2026 | May 13, 2026 |
| Thomas KeanHouse · R-New Jersey | Sale | $1,001 - $15,000 | Mar 10, 2026 | Apr 14, 2026 |
| Thomas KeanHouse · R-New Jersey | Sale | $1,001 - $15,000 | Feb 13, 2026 | Mar 18, 2026 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Sep 30, 2025 | Oct 13, 2025 |
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 29, 2025 | Oct 3, 2025 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Aug 26, 2025 | Sep 12, 2025 |
| Gilbert CisnerosHouse · D-California | Purchase | $1,001 - $15,000 | Aug 13, 2025 | Sep 12, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Waters
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 7,900
- Headquarters
- Milford, Massachusetts
- Website
- waters.com
- Listed
- Nov 17, 1995
More medical - diagnostics & research stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.